Open
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$209.63K

Rubinstein Julie President And COO

Transaction date Nov 4, 2026
Public filing date Nov 6, 2026
Filing lag Filed 2 days later

ADPT daily price context

Close on/before transaction
$26.71 Nov 4, 2026
First close after public filing
$30.26 Nov 9, 2026
Return after filing · so far
-0.26% Through Nov 11, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
7,881 shares @ $26.6
SEC ownership
Direct
Transaction code
S
Form
4
Filing identifier
0001780664-26-000051
Filing cohort

Transactions in this filing

Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$1.39M
Buys / sales
0 / 7
Transactions reported in the same official filing
Issuer Transaction Traded Value
Adaptive Biotechnologies Corp ADPT Sale Nov 6, 2026 $229.49K
Adaptive Biotechnologies Corp ADPT Sale Nov 6, 2026 $97.05K
Adaptive Biotechnologies Corp ADPT Exercise Nov 6, 2026 $0
Adaptive Biotechnologies Corp ADPT Exercise Nov 6, 2026 $144.24K
Adaptive Biotechnologies Corp ADPT Exercise Nov 5, 2026 $144.24K
Adaptive Biotechnologies Corp ADPT Sale Nov 5, 2026 $146.63K
Adaptive Biotechnologies Corp ADPT Sale Nov 5, 2026 $154.67K
Adaptive Biotechnologies Corp ADPT Exercise Nov 5, 2026 $0
Adaptive Biotechnologies Corp ADPT Sale Nov 5, 2026 $13.85K
Adaptive Biotechnologies Corp ADPT Current Sale Nov 4, 2026 $209.63K
Adaptive Biotechnologies Corp ADPT Exercise Nov 4, 2026 $144.24K
Adaptive Biotechnologies Corp ADPT Sale Nov 4, 2026 $103.12K
Adaptive Biotechnologies Corp ADPT Exercise Nov 4, 2026 $0